|Publication number||US20070150041 A1|
|Application number||US 11/444,603|
|Publication date||Jun 28, 2007|
|Filing date||May 31, 2006|
|Priority date||Dec 22, 2005|
|Also published as||EP1962722A2, EP1962722A4, WO2007092103A2, WO2007092103A3|
|Publication number||11444603, 444603, US 2007/0150041 A1, US 2007/150041 A1, US 20070150041 A1, US 20070150041A1, US 2007150041 A1, US 2007150041A1, US-A1-20070150041, US-A1-2007150041, US2007/0150041A1, US2007/150041A1, US20070150041 A1, US20070150041A1, US2007150041 A1, US2007150041A1|
|Inventors||Michael Evans, Gwendolyn Watanabe, Amy Lee, Steven Herbowy|
|Original Assignee||Nellix, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (5), Referenced by (11), Classifications (14), Legal Events (2)|
|External Links: USPTO, USPTO Assignment, Espacenet|
The present application claims the benefit of provisional application No. 60/753,327 (Attorney Docket No. 025925-001800US), filed Dec. 22, 2005, the full of disclosure of which is incorporated herein by reference.
1. Field of the Invention
The present invention relates generally to medical apparatus and methods for treatment. More particularly, the present invention relates to methods and systems for crossing and filling abdominal and other aneurysms.
Aneurysms are enlargements or “bulges” in blood vessels which are often prone to rupture and which therefore present a serious risk to the patient. Aneurysms may occur in any blood vessel but are of particular concern when they occur in the cerebral vasculature or the patient's aorta.
The present invention is particularly concerned with aneurysms occurring in the aorta, particularly those referred to as aortic aneurysms. Abdominal aortic aneurysms (AAA's) are classified based on their location within the aorta as well as their shape and complexity. Aneurysms which are found below the renal arteries are referred to as infrarenal abdominal aortic aneurysms. Suprarenal abdominal aortic aneurysms occur above the renal arteries, while thoracic aortic aneurysms (TAA's) occur in the ascending, transverse, or descending part of the upper aorta.
Infrarenal aneurysms are the most common, representing about eighty percent (80%) of all aortic aneurysms. Suprarenal aneurysms are less common, representing about 20% of the aortic aneurysms. Thoracic aortic aneurysms are the least common and often the most difficult to treat. Most or all present endovascular systems are also too large (above 12 F) for percutaneous introduction.
The most common form of aneurysm is “fusiform,” where the enlargement extends about the entire aortic circumference. Less commonly, the aneurysms may be characterized by a bulge on one side of the blood vessel attached at a narrow neck. Thoracic aortic aneurysms are often dissecting aneurysms caused by hemorrhagic separation in the aortic wall, usually within the medial layer. The most common treatment for each of these types and forms of aneurysm is open surgical repair. Open surgical repair is quite successful in patients who are otherwise reasonably healthy and free from significant co-morbidities. Such open surgical procedures are problematic, however, since access to the abdominal and thoracic aortas is difficult to obtain and because the aorta must be clamped off, placing significant strain on the patient's heart.
Over the past decade, endoluminal grafts have come into widespread use for the treatment of aortic aneurysm in patients who cannot undergo open surgical procedures. In general, endoluminal repairs access the aneurysm “endoluminally” through either or both iliac arteries in the groin. The grafts, which typically have been fabric or membrane tubes supported and attached by various stent structures, are then implanted, typically requiring several pieces or modules to be assembled in situ. Successful endoluminal procedures have a much shorter recovery period than open surgical procedures.
Present endoluminal aortic aneurysm repairs, however, suffer from a number of limitations. A significant number of endoluminal repair patients experience leakage at the proximal juncture (attachment point closest to the heart) within two years of the initial repair procedure. While such leaks can often be fixed by further endoluminal procedures, the need to have such follow-up treatments significantly increases cost and is certainly undesirable for the patient. A less common but more serious problem has been graft migration. In instances where the graft migrates or slips from its intended position, open surgical repair is required. This is a particular problem since the patients receiving the endoluminal grafts are often those who are not considered good candidates for open surgery. Further shortcomings of the present endoluminal graft systems relate to both deployment and configuration. Current devices are unsuitable for treating many geometrically complex aneurysms, particularly infrarenal aneurysms with little space between the renal arteries and the upper end of the aneurysm, referred to as short-neck or no-neck aneurysms. Aneurysms having torturous geometries, are also difficult to treat.
For these reasons, it would be desirable to provide improved methods and systems for the endoluminal and minimally invasive treatment of aortic aneurysms. In particular, it would be desirable to provide systems and methods which provide prostheses with minimal or no endoleaks, which resist migration, which are relatively easy to deploy, and which can treat many if not all aneurysmal configurations, including short-neck and no-neck aneurysms as well as those with highly irregular and asymmetric geometries. It would be further desirable to provide systems and methods which are compatible with current designs for endoluminal stents and grafts, including single lumen stents and grafts, bifurcated stents and grafts, parallel stents and grafts, as well as with double-walled filling structures which are the subject of the commonly owned, copending applications described below. The systems and methods would preferably be deployable with the stents and grafts at the time the stents and grafts are initially placed. Additionally, it would be desirable to provide systems and methods for repairing previously implanted aortic stents and grafts, either endoluminally or percutaneously. At least some of these objectives will be met by the inventions described hereinbelow.
2. Description of the Background Art
US2006/0025853 describes a double-walled filling structure for treating aortic and other aneurysms. Copending, commonly owned application Ser. No. 11/413,460, describes the use of liners and extenders to anchor and seal such double-walled filling structures within the aorta. The full disclosures of both these pending applications are incorporated herein by reference. WO 01/21108 describes expandable implants attached to a central graft for filling aortic aneurysms. See also U.S. Pat. Nos. 5,330,528; 5,534,024; 5,843,160; 6,168,592; 6,190,402; 6,312,462; 6,312,463; US2002/0045848; US2003/0014075; US2004/0204755; US2005/0004660; and WO 02/102282.
The present invention provides methods and systems for the treatment of aneurysms, particularly aortic aneurysms including both abdominal aortic aneurysms (AAA's) and thoracic aortic aneurysms (TAA's). Treatments are particularly useful in endoluminal protocols where vascular catheters may be used to advance and manipulate the various system components. In some instances, however, the systems and methods will also be useful for the percutaneous, minimally invasive treatment of aneurysms where the aneurysm may be accessed from the outside through a controlled penetration in the aneurysmal wall.
Systems according to the present invention comprise a scaffold which is adapted to be placed across the aneurysm to provide one or more blood flow lumens thereacross. The scaffold may be any type of conventional aneurysmal treatment scaffold, including bare stents, grafts, stent-reinforced grafts, double-walled filling structures (as described in detail in copending application Ser. No. 11/413,460, the full disclosure of which has been previously incorporated herein by reference), and the like. Optionally, the scaffold will be coated with, impregnated with, or otherwise adapted to carry a medicament which will be released in the aneurysmal sac after the scaffold is implanted therein. The present invention will primarily rely on stents and grafts which are endoluminally placed to provide the desired blood flow lumen(s) across the aneurysm and to define an aneurysmal space between an outside surface of the scaffold and an inside surface of all or a portion of the aneurysmal wall. As discussed above in the Background section, the aneurysmal space which remains around an aneurysmal scaffold is subject to leakage and in some cases allows for migration of the scaffold from the originally implanted location. Both outcomes are undesirable, and the methods and systems of the present invention will help both seal the aneurysmal space in order to reduce the risk of leakage and help anchor the aneurysmal scaffold in place to reduce the risk of migration.
The present invention provides for the deployment of one or more expandable structures, such as inflatable balloons or bladders, within the aneurysmal space. The expandable structures are usually placed after deployment of the aneurysmal scaffold and more usually are deployed through the wall of the scaffold into the aneurysmal space. In other instances, however, the space-filling expandable structures may be deployed prior to placement of the aneurysmal scaffold, where such pre-deployed expandable structures may be expanded either before or after deployment of the aneurysmal scaffold. In other instances, the expandable structures of the present invention may be deployed days, weeks, or even longer after an initial endoluminal or other aneurysmal repair. The expandable structures are useful for developing voids which may open around a previously implanted scaffold over time. For such “revision” treatments, the expandable structures may be placed through the aneurysmal scaffold or may be percutaneously placed through the wall of the aneurysm.
When filling the aneurysmal space after deployment of an aneurysmal scaffold, it is necessary to avoid over pressuring the aneurysmal sac in order to reduce the risk of accidental rupture. The present invention provides different protocols for controlling pressurization within the aneurysmal space as the expandable structure is being expanded. For example, excess expansion medium being fed to one or more of the expandable structures may be selectively bled from the structure if the pressure within the aneurysmal space is excessive. A drain tube or lumen may be connected to the expandable structure while it is being expanded in order to bleed the excess expansion medium. Such selective bleeding could be controlled by a pressure relief valve, a feedback pressure control system, or the like. Alternatively, excessive pressurization within the aneurysmal sac can be controlled by bleeding fluid from the aneurysmal space as the expandable structure is being expanded. Such control could be provided by one or more drain catheters deployed directly into the aneurysmal space and connected to pressure relief valves or active pressure control systems.
In a first aspect of the present invention, methods are provided for treating an aneurysm in a blood vessel by placing a scaffold across the aneurysm to define an aneurysmal space between an outside surface of the scaffold and an inside surface of the aneurysmal wall. At least one expandable structure is expanded using an expansion medium which passes by or through the scaffold or through the aneurysmal wall to fill at least a portion of the aneurysmal space.
The scaffold may comprise any conventional vascular scaffold of a type which may be positioned across an aneurysm. For example, the scaffold could comprise a conventional bare metal stent having sufficient length and suitable diameter to be implanted across the aneurysm with a first end anchored in healthy vasculature on one side of the aneurysm and a second end anchored in healthy vasculature on the other side of the aneurysm. Such bare metal stents may be balloon expandable, self-expanding, provide for a ratcheting expansion, or the like. Alternatively, fabric, braid, or other vascular grafts may be anchored in healthy vasculature on either side of the aneurysm, often using barbs, staples, or the like. The graft structures will typically comprise a blood-impermeable wall, and thus the expandable structures will typically be delivered before graft deployment, around a partially deployed graft, or through the aneurysmal wall, as described generally below. In addition to stents and grafts, the present invention can use stent-reinforced graft structures which are typically expanded and anchored within the target blood vessel. Such stent-grafts may also be balloon expandable, self-expanding, or a combination thereof.
The systems and methods of the present invention may be used to treat aneurysms having a variety of geometries. While the systems and methods are particularly useful for treating aneurysms wherein the enlargement circumscribes the blood vessel (fusiform), such as most aortic aneurysms, they will also be useful for treating various asymmetric aneurysms where the bulge is present over only a portion of the periphery of the blood vessel wall. In all cases, it is generally desirable that the expandable structures occupy at least most and preferably all of the void in the aneurysmal space in order to most effectively inhibit leakage and migration of the scaffold.
The methods and systems of the present invention are compatible with the use of both single scaffolds and multiple scaffold systems. In treating linear aneurysms, two or more stents, grafts, or other scaffolds may be placed in series in order to span the entire length of the aneurysm. In bifurcated aneurysms, such as abdominal aortic aneurysms, a pair of parallel scaffolds may be placed in the aneurysm and extend from the aorta into each of the iliac branch vessels. Alternatively, bifurcated scaffolds having branch ends may be placed from the aorta into the iliac arteries. When treating such branch vessels, it will also be possible to add stents, cuffs, and other sealing members which extend the length of the scaffold at either end.
The expandable structures will typically be balloons or other structures which are inflatable with a fluid inflation medium. Such inflatable structures will typically have a fluid impermeable wall which is sufficiently flexible to conform to the aneurysmal wall, the scaffold, and other expandable structure(s) which may be or have been placed in the aneurysmal space. The inflatable structures may be elastic or non-elastic, typically being formed from parylene, polyester (e.g., DacronŽ), PET, PTFE, and/or a compliant material, such as silicone, polyurethane, latex, or combinations thereof. Usually, it will be preferred to form at least a portion of the inflatable member partially or entirely from a non-compliant material to enhance conformance of the outer wall of the scaffold to the inner surface of the aneurysm.
The walls of the expandable structures may consist of a single layer or may comprise multiple layers which are laminated, glued, heat bonded, ultrasonically bonded, or otherwise formed together. Different layers may comprise different materials, including both compliant and/or non-compliant materials. The structure walls may also be reinforced in various ways, including braid reinforcement layers, filament reinforcement layers, and the like.
The expandable structures of the present invention may also be expanded with non-fluid expansion medium, such as powders, pellets, coils, foams, and the like. In such instances, the expandable structure will not necessarily be formed from an impermeable material, but instead could be formed from lattices, braids, nets, or other permeable or foramenous structures which contain the expansion medium but might permit blood and fluid permeation.
In some instances, the expandable structure will be extruded in situ, typically at the same time that it is being expanded or inflated with a separate expansion material. Various extrudable polymers exist which can be delivered from a delivery catheter.
Expanding the expandable structure will usually be performed at least in part using a delivery catheter which both positions and fills the expansion structure within the aneurysmal space. Most commonly, the delivery catheter will be positioned inside of the scaffold and will deliver the expansion medium through the catheter wall. In other instances, however, the delivery catheter may be positioned around one end of the scaffold to permit positioning and filling of the expandable structure before or after the scaffold has been placed. In still further instances, the delivery catheter may be passed through a penetration in the aneurysmal wall to access a void in the aneurysmal space which requires filling.
In a first exemplary embodiment, the delivery catheter will be used to deliver and position the expandable structure through the scaffold wall after the scaffold has been placed in the aneurysm. The delivery catheter may be passed through a discrete window or opening formed in the scaffold wall which is enlarged relative to other openings and intended particularly for delivering the expandable structure. More typically, however, the delivery catheter will be passed through openings or interstices which are inherently part of the cellular construction of the scaffold. By passing through the cellular openings which are already present, multiple expandable structures may be placed at locations which may be determined during the course of the procedure.
In alternative protocols, the delivery catheter may be used to place the expandable structure prior to delivery of the scaffold. The scaffold may then be placed so that at least one end of the scaffold is deployed and anchored over the delivery catheter(s). In such instances, the expandable structures will usually be inflated or otherwise expanded after the scaffold is deployed. Alternatively, the expandable structures may be expanded at least partly prior to deployment of the scaffold so long as care is taken not to over pressurize the aneurysmal sac when the scaffold is expanded and implanted.
In yet another protocol, the delivery catheter may be introduced into the aneurysmal space by passing a cannula or other delivery tube through a penetration in the aneurysmal wall. The cannula may be positioned using thoracoscopic or other minimally invasive techniques in order to access the outside wall of the aneurysm. Such percutaneous deployment of the expandable structures will be particularly suitable for treating patients where a void or expansion of the aneurysmal sac has occurred sometime after a primary treatment.
Usually, at least two expandable structures will be delivered to substantially fill the aneurysmal space. Often, three, four, five, or even more expandable structures may be delivered. Typically, the treating physician will sequentially deliver multiple expandable structures through the wall of the aneurysmal scaffold while visualizing the aneurysmal space fluoroscopically. A sufficient number of expansion members can then be delivered in order to substantially fill the void within the aneurysmal space, as confirmed by the fluoroscopic visualization. In other instances, two or more expandable structures may be expanded simultaneously, in mixed protocols where expandable structures are sometimes delivered simultaneously and other times delivered sequentially may also be employed.
In a second aspect of the present invention, systems for treating an aneurysm in a blood vessel comprise a scaffold, and expandable structure, and a delivery catheter. The scaffold may comprise any of the scaffolds generally described above in connection with the methods of the present invention. The delivery catheters will typically comprise a flexible elongate tubular member having at least one lumen therethrough for delivering expansion medium to the expandable structure. In some embodiments, the expandable structure may be initially attached at a distal end of a delivery catheter and the lumen of the delivery catheter used only for delivering the expansion medium to the expandable structure. The expandable structure will be detachable from the delivery catheter after it has been filled and will usually include a self-sealing valve or other attachment port which closes and retains the expansion medium within the structure after detachment of the delivery catheter. In other instances, the delivery catheter may be adapted to deliver both the expandable structure and the expansion medium to the expandable structure. In such instances, the delivery catheter can be used for sequentially delivering two or more expansion structures together with filling of those structures. In still other instances, separate delivery catheters or delivery catheter components may be used for delivering an expandable structure and for filling the expandable structure.
The systems of the present invention may further comprise a cannula for positioning a delivery catheter and expandable structure percutaneously through the wall of an aneurysm. The cannula will have an axial lumen for containing the expandable structure and/or delivery catheter can be used to access the aneurysm in a conventional manner.
Referring now to
Use of a single delivery catheter 12 for sequentially positioning a plurality of expandable structures 16 a-16 c is illustrated in
Referring now to
Referring now to
Referring now to
The expandable structure 16 can take a variety of forms. As shown in
Referring now to
As described thus far, the expandable structures 16 have been delivered from a central lumen or passage of the scaffold into the aneurysmal space surrounding the scaffold. As an alternative, the expandable structures may also be delivered by positioning a delivery catheter on the outside of the scaffold, as illustrated generally in
In all deployment protocols described thus far which employ open lattice or mesh scaffolds, it will be appreciated that expansion of the expandable structures within the aneurysmal space may displace fluid or materials present in the aneurysmal space into the lumen of the scaffold. This is advantageous since it reduces the risk of over pressurization of the aneurysmal sac.
Referring now to
While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2151733||May 4, 1936||Mar 28, 1939||American Box Board Co||Container|
|CH283612A *||Title not available|
|FR1392029A *||Title not available|
|FR2166276A1 *||Title not available|
|GB533718A||Title not available|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7790273||May 23, 2007||Sep 7, 2010||Nellix, Inc.||Material for creating multi-layered films and methods for making the same|
|US7951448||Aug 17, 2010||May 31, 2011||Nellix, Inc.||Material for creating multi-layered films and methods for making the same|
|US8048145||Apr 28, 2006||Nov 1, 2011||Endologix, Inc.||Graft systems having filling structures supported by scaffolds and methods for their use|
|US8182525||Apr 9, 2009||May 22, 2012||Endologix, Inc.||Methods and systems for endovascular aneurysm treatment|
|US8444624||Oct 19, 2009||May 21, 2013||Vatrix Medical, Inc.||Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections|
|US8911468||Jan 31, 2012||Dec 16, 2014||Vatrix Medical, Inc.||Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection|
|US8926682||Sep 23, 2011||Jan 6, 2015||Nellix, Inc.||Stent graft delivery system|
|WO2009132309A1 *||Apr 24, 2009||Oct 29, 2009||Nellix, Inc.||Stent graft delivery system|
|WO2012068298A1 *||Nov 16, 2011||May 24, 2012||Endologix, Inc.||Devices and methods to treat vascular dissections|
|WO2013025493A1 *||Aug 10, 2012||Feb 21, 2013||W.L. Gore & Associates, Inc.||Systems for the reduction of leakage around medical devices at a treatment site|
|WO2014117127A1 *||Jan 28, 2014||Jul 31, 2014||Neurodynamics, LLC||Embolic coil delivery system and method of using same|
|Cooperative Classification||A61B17/12118, A61F2002/065, A61F2/07, A61B2017/1205, A61F2230/0078, A61F2002/077, A61B17/12136, A61B2017/00893, A61F2/90|
|European Classification||A61F2/07, A61B17/12P7B, A61B17/12P5B1S|
|Aug 18, 2006||AS||Assignment|
Owner name: NELLIX, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:EVANS, MICHAEL A.;WATANABE, GWENDOLYN A.;LEE, AMY;AND OTHERS;REEL/FRAME:018142/0290
Effective date: 20060719
|Jun 15, 2011||AS||Assignment|
Owner name: ENDOLOGIX, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NELLIX, INC.;REEL/FRAME:026456/0171
Effective date: 20110523